Related Experiment Videos
Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand?'
1Departmet of Medical Biochemistry and Biophysics, Section of Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden rikard.holmdahl@ki.se.
Annals of the Rheumatic Diseases
|June 23, 2019
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Anti-Tumoral Treatment with Thioredoxin Reductase 1 Inhibitor Auranofin Fosters Regulatory T Cell and B16F10 Expansion in Mice.
Antioxidants (Basel, Switzerland)·2025
Self-Antigens Select B Cells: A New Perspective on B Cell Selection and Function.
European journal of immunology·2025
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Annals of the rheumatic diseases·2026
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Annals of the rheumatic diseases·2026
Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.
Annals of the rheumatic diseases·2026
Number Needed to Treat Analysis for Ground Prehospital Blood in Hemorrhagic Shock.
Journal of the American College of Surgeons·2026
A proactive large platelet-driven screening strategy for the early recognition of MYH9-related disease: a Chinese prospective cohort study.
Research and practice in thrombosis and haemostasis·2026